MeiraGTx Holdings plc (FRA:328)

Germany · Delayed Price · Currency is EUR

6.30

-0.10 (-1.56%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development and Manufacturing of Genetic Medicines	33.28M	14.02M	15.92M	37.70M	15.56M
Development and Manufacturing of Genetic Medicines Growth	137.42%	-11.95%	-57.77%	142.25%	17.09%
Total	33.28M	14.02M	15.92M	37.70M	15.56M
Total Growth	137.42%	-11.95%	-57.77%	142.25%	17.09%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United Kingdom	33.28M	14.02M	15.92M	37.70M	15.56M
United Kingdom Growth	137.42%	-11.95%	-57.77%	142.25%	17.09%
Total	33.28M	14.02M	15.92M	37.70M	15.56M
Total Growth	137.42%	-11.95%	-57.77%	142.25%	17.09%

Source: S&P Global Market Intelligence.